Zusammenfassung
Unabhängig davon, ob bakterielle Toxine oder andere primär nichtbakterielle Aggressionen Auslöser für eine schließlich generalisierte Entzündungsreaktion des Organismus sind, immer werden die gleichen klassischen Kaskadensysteme angeregt:
-
das Komplementsystem,
-
das Gerinnungs-Fibrinolyse-System,
-
das Kallikrein-Kinin-System.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Asanuma Y, Takahashi T, Kato T, Kudo K, Koyama K (1989) Treatment of endotoxin shock due to gramnegative bacteremia using extracorporal circulation. Nippon-Shokakibyo- GakkaiZasshi 86: 246–252
Asanuma Y, Takahashi T, Koyama K et al. (1989) Exchange blood transfusion and on-line plasma exchange for sepsis in infants. ASAIO Trans 35: 343–345
Bambauer R, Meyer S, Jung H, Goehl H, Nystrand R (1990) Sterile vs. non-sterile dialysis fluid in chronic hemodialysis treatment. ASAIO Trans 36: 317–320
Barckow D, Schirop T (1983) Isolierte Ultrafiltration beim akuten Lungenversagen. Intensivmedizin 20: 213–216
Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Ben Zeev I (1989) Use of extracorporeal supportive techniques as additional treatment for multiple organ failure patients. Crit Care Med 17: 634–637
Baumann J,Kiene S, Kampfer I, Hofmann J (1991) Animal experiment studies of the distribution and elimination of marked endotoxin. Zentralbl Chir 116: 969–981
Baurmeister U, Travers M, Vienken J et al. (1989) Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes. ASAIO Trans 35: 519–522
Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients [see comments]. Crit Care Med 21: 522–526
Bende S, Bertok L (1986) Elimination of endotoxin from the blood by extracorporeal activated charcoal hemoperfusion in experimental canine endotoxin shock. Circ Shock 19: 239–244
Beutler B, Cerami A (1987) The biology of cachectin/TNF–a primary mediator of the host response. Ann Rev Immunol 7: 625–655
Bjorvatn B, Bjertnaes L, Fadnes HO et al. (1984) Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J 288: 439–441
Bone RC, Balk RA, Cerra FB et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644–1655
Bottoms G, Fessler J, Murphey E et al. (1998) Efficacy of convective removal of plasma mediators of endotoxic shock by continuous veno-venous hemofiltration. Shock 5: 149–54 (issn 1073–2322)
Bozkurt F, Hörl WH (1987) Bedeutung der kontinuierlichen arteriovenösen Hämofiltration (CAVA) and arteriovenösen Hämodiafiltration ( AV-HDF) in der Intensivtherapie. Intensivmedizin 24: 248–254
Brigham KL, Meyrick B (1986) Endotoxin and lung injury. Am Rev Respir Dis 133: 913–927
Brunet P, Jaber K, Berland V, Baz M (1992) Anaphylactoid reactions during hemodialysis and hemofiltration: role of AN69 membrane and angiotensin I-converting enzyme inhibitors. Am J Kidney Dis 19: 444 447
Bysani GK, Shenep JL,Hildner WK, Stidham GL, Roberson PK (1990) Detoxification of plasma containing lipopolysaccharide by adsorption. Crit Care Med 18: 67–71
Carozzi S, Nasini MG, Caviglia PM, Schelotto C, Santoni O, Atti M(1992) Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release. ASAIO Trans 38: 52–54
Cheadle WG, Hanasawa K, Gallinaro RN et al. (1991) Endotoxin filtration and immune stimulation improve survival from sepsis. Surgery 110: 785–791
Colton CK (1978) Analysis of membrane processes for blood purification. Blood Purif 5: 202–251
Coraim F, Pongratz-Coraim H, Mauritz W, Ebermann R (1986) Hämofiltration als Therapie des akuten Lungenversagens im kardiogenen Schock. Anästhesist 35: 187–192
Dietz T (1983) Untersuchungen zur Elimination von Endotoxin in vitro. Inauguraldissertation, Berlin
Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095–2147
Dobos GJ, Meske S, Keller E et al. (1990) Successful therapy of meningococcal sepsis in acute disseminated lupus with plasmapheresis, immunosuppression and antibiotics. Klin Wochenschr 68: 76–980
Druml W (1995) Nonrenal indications for continuous hemofiltration therapy in patients with normal renal function. In: Sieberth HG, Stummvoll HK, Kierdorf H (eds) Continuous extra-corporal treatment in multiple organ dysfunction syndrome. Karger, Basel (Contrib Nephrol, vol 116 ), pp 121–129 )
Fisher CJ, Panacek EA (1989) Toxic shock syndrome. In: Shoemaker WC, Ayres S, Grenvik A, Holbrook RR, Thompson WL (eds) Textbook of critical care. Saunders, Philadelphia
Golper TA, Jenkins R, Wright M, Klein JB (1990) Tumor necrosis factor ( TNF) and hemofiltration membranes. Intensivbehandlung 15: 119
Gomez A, Wang R, Unruh H et al. (1990) Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73: 671–685
Gotloib L, Barzilay E, Shustak A, Wais Z, Jaichenko J, Lev A (1986) Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 13: 123–132
Graben N (1980) Entgiftung mit Hämoperfusion. Bindernagel, Friedberg
Groeneveld ADJ (1990) Septic shock and multiple organ failure: treatment with hemofiltration? Intensive Care Med 16: 489–490
Hanasawa K, Aoki H, Yoshioka T, Matsuda K, Tani T, Kodama M (1989) Novel mechanical assistance in the treatment of endotoxic and septicemic shock. ASAIO Trans 35: 341–343
Hanasawa K, Tani T, Kodama M (1989) New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber. Surg Gynecol Obstet 168: 323–331
Heering P, Morgera S,.Schmitz FJ, Willers R, Schultheiss HP, Strauer BE, Grabensee B (1997) Cytokine removal and cardivascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23: 288–296
Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D (1995) Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances. Kidney Int 48: 1563–1570
Hoffmann JN, Hartl WH, Deppisch R, Faist E, Jochum M, Inthorn D (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22: 1360–1367
Hogquist KA, Unanue ER, Chaplin DD (1991) Release of IL-1 from mononuclear phagocytes. J Immunol 147: 2181–2186
Journois D, Pouard P, Greeley WJ, Mauriat P, Vouhé P, Safran D (1994) Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 81: 1181–1189
Klinkmann H, Falkenhagen D, Smollich BP (1985) Investigation of the permeability of highly permeable polysulfone membranes for pyrogens. Karger, Basel (Contr Nephrol, vol 46 ), pp 147–183
Koller WF, Benzer HM, Pauser GF (1985) CAVH in acute respiratory failure. In: Sieberth HG, Mann H (eds) Continuous arteriovenous hemofiltration (CAVH). Karger, Basel
Kramer P, Wigger W, Rieger J, Matthai D, Scheler F (1977) Arteriovenous haemofiltration: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55: 1121–1122
Laude-Sharp M, Caroff M, Simard L et al. (1990) Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins ( LPS ). Kidney Int 38: 1089–1094
Luderitz O, Galanos C, Lehmann V et al. (1973) Lipid A: Chemical structure and biological activity. J Infect Dis 128 Suppl: 17–29
Mauritz W, Sporn P, Schindler I, Zadrobilek E, Roth E, Appel W (1986) Akutes Nierenversagen bei abdomineller Sepsis. Anästh Intensivther Notfallmed 21: 212–217
May LT, Santhanam U, Sehgal PB (1991) On the multimeric nature of natural human interleukin-6. J Biol Chem 266: 9950–9955
McCelland P, Williams PS, Yaqoob M, Mostafa SM, Bone JM (1990) Multiple organ failure:a role for plasma exchange? Intensive Care Med 16: 100–103
Nakamura Y, Wakabayashi A, Wolley T, Mullin P, Ito Y, Connolly JE (1976) Total body washout for the treatment of endotoxin shock. Arch Surg 111: 783–786
Nemes C, Niemer M (1992) Blutreinigungsverfahren. In: Niemer M, Nemes C, Lundsgaardhansen P, Blauhuth B (Hrsg) Datenbuch Intensivmedizin.G. Fischer, Stuttgart Jena
Nieter B, Sisova S, Klug C et al. (1991) Plasmaaustausch bei septisch-toxischen Krankheitsbildern. Nieren Hochdruckkrankh 20: 155–159
Nisbeth U, Hallgren R, Eriksson O, Danielson BG (1987) Endotoxemia in chronic renal failure. Nephron 45: 93–97
Olbricht CJ (1992) Pharmakotherapie bei kontinuierlicher Hämofiltration. Intensivmedizin 29: 4–8
Ossenkoppele GJ, Meulen J van der, Bronsveld W, Thijs LG (1985) Continuous arteriovenous hemofiltration as an adjunctive therapy for septic shock. Crit Care Med 13: 102–104
Osterud B (1985) Meningococcal septicemia: the use of plasmapheresis or blood exchange and how to detect severe endotoxin induced white cell activation. Scand J Clin Lab Invest Suppl 178: 47–51
Pegues AS, Sofer SS, McCallum RE, Hinshaw LB (1979) The removal of C14 labeled endotoxin by activated charcoal. Int J Artif Org 2: 153–158
Pusey CD, Aslam M, Cohen J, Courtney JM, Ryan CJ (1991) Experimental models of plasma perfusion. J Clin Apher 6: 99–102
Rietschel ET, Brade H (1987) Lipopolysaccharide, die Endotoxine and 0-Antigene gramnegativer Bakterien: Chemische Struktur, biologische Wirkung and serologische Eigenschaften. Infection 15: 576–584
Röckel A,Abdelhamid S, Fliegel P, Walb D (1985) Elimination of low molecular weight proteins with high flux membranes. Karger, Basel (Contr Nephrol, vol 46 ), pp 69–74
Roth RI, Levin FC, Levin J (1993) Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin. Infect Immun 61: 3209–3215
Roth RI, Kaca W, Levin J (1994) Hemoglobin: a new recognized binding protein for bacterial endotoxins ( LPS ). Prog Clin Biol Res 388: 161–172
Sander A, Armbruster W, Sander B, Daul AE, Lange R, Peters J (1997) Hemofiltration increases IL-6 clearance in early inflammatory response syndrome but does not alter IL-6 and TNFplasma concentrations. Intensive Care Med 23: 878–884
Sawada K, Malchesky PS, Nose Y (1990) Available removal sytems: State of the art. In: Nydegger VE (ed) Therapeutic hemopheresis in the 1990’s. Karger Basel (Curr Stud Hematol Blood Tranfus, vol 57 ), pp 51–113 )
Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P (1995) Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 21: 169–175
Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA (1990) Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 37: 85–93
Schindler R, Linnenweber S, Schulz M et al. (1993) Gene expression of interleukin-1 beta during hemodialysis. Kidney Int 43: 712–21
Schindler R, Lufft V, Lonnemann G et al. (1996) Induction of interleukin-1 and interleukin-1 receptor antagonists during contaminated dialysis with whole blood. Nephrol Dial Transplant 11: 101–108
Schwerdtfeger R (1993) Verhalten der Plasmaproteine bei verschiedenen Methoden der therapeutischen Plasmapherese: Untersuchungen zur Notwendigkeit von Sekundärsystemen. Habilitationsschrift, Berlin
Sieberth HG (1982) Apparative Detoxikation: Plasmaseparation.Intensivmedizin 19: 74–78
Smith RA., Baglioni C (1986) The active form of tumor necrosis factor is a trimer. J Biol Chem 262 2345–2354
Staubach KH, Rau HG, Kooistra A et al. (1989) Can hemofiltration increase survival time in acute endotoxemia-a porcine shock model. Prog Clin Biol Res 308: 821–826
Steel CM, Hutchins D (1989) Soluble factors and cell-surface molecules involved in human B lymphocyte activation, growth and differentiation. Biochim Biophys Acta 989: 133–151
Stein B, Pfenninger E, Grunert A, Schmitz JE, Deller A, Kocher F (1991) The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med 17: 293–298
Stokes DC, Shenep JL, Fishman M (1989) Polymyxin B prevents lipopolysaccharide induced release of tumor necrosis factor-alpha from alveolar macrophages. J Infect Dis 160: 52–57
Storck M, Hartl WH, Zimmerer E, Inthorn D (1991) Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 337: 452–455
Susini G, Zuccetti M, Bortone F et al. (1990) Isolated ultrafiltration in cardiogenic pulmonary edema. Crit Care Med 18: 14–17
Tani T,Hanasawa K, Kodama M (1989) Usefulness of endotoxic removal from the septic blood with direct hemoperfusion using PMX-F. Nippon Geka Gakkai Zasshi 90: 1370–1373
Tetta C, Camussi G, Turello et al. (1990) Production of cytokines in hemodialysis. Blood Purif 8: 337–346
Vanholder R,Van Haecke E, Veys N, Ringoir S (1992) Endotoxin transfer through dialysis membranes: small vs. large pore membranes. Nephrol Dial Transplant 7: 333–339
Wegmüller E (1981) Die therapeutische Bedeutung der Plasmapherese bei Immunkrankheiten. Schweiz Med Wochenschr 111: 443–449
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Barckow, D. (2000). Extrakorporale Therapieverfahren bei Sepsis — Hämofiltration, Plasmapherese, Hämoperfusion. In: Schuster, HP., Werdan, K. (eds) Intensivtherapie bei Sepsis und Multiorganversagen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07962-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-07962-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-07963-8
Online ISBN: 978-3-662-07962-1
eBook Packages: Springer Book Archive